02 Mar 2021

Sunny days for Bluefield

Sunny days for Bluefield – Bluefield Solar’s interim results for the six months ended 31 December continue on a positive note. Highlights are: Shareholders approved an expansion of the company’s remit to include investment outside of solar infrastructure assets, notably wind and energy storage. Shareholders also approved an update to the dividend policy. Bluefield completed […]

02 Mar 2021

RIT Capital shrugs off effects of virus

RIT Capital shrugs off effects of virus – RIT Capital Partners results for the year ended 31 December 2020 show an NAV total return of 16.4% for the year, which compares to 12.7% for the MSCI All Countries World Index and 4.2% for the company’s performance objective of inflation (as measured by the RPI) plus 3% […]

02 Mar 2021

Apax Global Alpha posts strong returns for 2020

Apax Global Alpha’s results for the year ended 31 December 2020 show the company generating a return of 14.8% on NAV, as the NAV hit €2.45 (219p) at the year end and the company declared dividends totalling 10.15p for the year. The private equity portfolio generated a return of 25.4% in euros (the currency that […]

02 Mar 2021

QuotedData’s morning briefing 2 March 2021

In QuotedData’s morning briefing 2 March 2021: Syncona (SYNC) notes that Achilles Therapeutics, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumours, announced it has filed a registration statement in  relation to a proposed IPO. Syncona owns 44% of Achilles which it values at £72.4m. RTW Venture Fund (RTW) participated in a Series […]

26 Feb 2021

RTW backs Artiva Biotherapeutics

RTW backs Artiva Biotherapeutics – RTW Venture Fund notes the announcement by Artiva Biotherapeutics of its completion of a $120m Series B financing round. RTW Venture Fund, alongside other of the investment manager’s vehicles, confirms that it participated in the financing round together with other investment firms. Roderick Wong, MD, managing partner and chief investment officer […]

26 Feb 2021

QD view – the rewards of truly patient capital

One of this week’s highlights was Herald’s (HRI’s) annual results for the year ended 31 December 2020. The performance numbers are impressive, a 37% return on NAV and a 51% return for shareholders, helped by some discount narrowing. Herald also celebrated another milestone, you may remember that back in 2017, we published a note – […]

25 Feb 2021

Greencoat UK Wind held back by falling premium

Greencoat UK Wind held back by falling premium – Greencoat UK Wind has announced final results for the year to 31 December 2020. While the NAV increased from 119.7p to 120.4p (+0.6%) during the year, the return to shareholders was -6.2% as the premium fell. This may reflect share issuance but falling power prices have also weighed on […]

25 Feb 2021

Troy’s Francis Brooke secures promotion

Troy’s Francis Brooke secures promotion – Francis Brooke, who has managed the £3.3bn Trojan Income Fund since its launch in October 2004 and the £241m Troy Income & Growth Trust since 2009, will be relinquishing his fund management responsibilities on 31st December 2021 and taking up a new role as executive vice-chairman of Troy Asset Management […]

25 Feb 2021

QuotedData’s morning briefing 25 February 2021

In QuotedData’s morning briefing 25 February 2021: Following its recent good news, KKV Secured Loan Fund will hand back 5p per share (£17.8m) to ordinary shareholders and 12p per share (£16.7m) to C shareholders. The ex date for these distributions will be 5 March 2021 and payment should arrive within the next couple of weeks after […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…